WovenX (formerly Telebelly Health) is a Chicago-based, AI-enabled specialty-care platform that pairs virtual, GI-trained Advanced Practice Providers with in-network brick-and-mortar practices to compress specialty appointment wait times from ~60 days to ~11 minutes and procedure wait times from ~10 weeks to ~2 weeks. The company has served 140,000+ patients in its beachhead specialty (gastroenterology), closed enterprise agreements with GI Alliance, Gastro Health, Idaho GI, and Washington Gastroenterology, and just finalized a pilot with Exact Sciences that carries $250–$330K near-term and up to $15M in annual expansion value.
Thesis: WovenX is a rare digital-health seed earning real GAAP revenue ($2.3M 2025, $4M CARR, $6M 2026 target) in a $400B+ specialty access market that health systems and payers are actively trying to fix — and StoryHouse can co-lead a priced Series Seed at $16M pre alongside Corazon Capital, taking meaningful Fund II ownership behind a management team that previously helped build and sell MDLIVE. The drag on conviction is a bruising four-month fundraise: despite a term sheet in hand and audited traction, the company could not attract a healthcare-focused institutional check and had to defend $16M pre against a $12M pre insider fallback, which signals downstream Series A pricing risk and softer market validation than the operating metrics suggest.
The specialty-access wedge is real: US gastroenterology has the longest specialist wait times of any surgical specialty and accounts for a disproportionate share of avoidable ED utilization. The company’s $400B+ framing is the full specialty-care spend; the immediately serviceable slice (GI virtual-care software plus APP staffing to health-system partners) is materially smaller but is compounding above 20% annually and sits inside a global telehealth market growing from $186B (2025) to $219B (2026) Web. TAM alone is not the constraint here — the constraint is enterprise sales cycles into large GI groups and health systems.
| Company | Positioning | Traction / Note | Source |
|---|---|---|---|
| WovenX Health | Virtual-first GI specialty platform & APP network integrated with brick-and-mortar practices; agentic AI supervision (100% chart review, 15 functional agents) | 140K+ patients, $4M CARR, 11-min access, 80+ NPS | Internal |
| GI Alliance in-house digital | Largest US GI roll-up’s internal digital access & scheduling stack (Cardinal Health acquired GI Alliance in 2025) | WovenX is a paid partner, not a competitor; roll-up scale creates distribution risk if in-house build accelerates | Web |
| Oshi Health | Virtual GI clinic, direct-to-employer / payer distribution | Peterson Health Institute validated real savings ~$2.5K/patient vs. claimed $10K across GI digital cohort | Web |
| Vivante Health (GIThrive) | Digital GI benefit for self-insured employers | Payer/employer channel; different buyer than WovenX’s health-system focus | Web |
| Cylinder / K Health GI | Consumer-facing digestive-health apps & asynchronous virtual care | Consumer-first; do not deliver procedural throughput to ASCs | Web |
| MDLIVE / Teladoc specialty | Broad multi-specialty telehealth | WovenX CTO / product team previously scaled MDLIVE (acquired by Cigna) — same playbook, GI-specialized | Internal |
Moat: WovenX is the only asset positioned squarely at the health-system / practice buyer with a hybrid model that both routes patients and unlocks procedural throughput inside partner ASCs — its distribution partnerships with the three largest US GI groups create a two-sided data set (4K+ recorded hours, 8M+ data points) that pure D2C or employer-benefit competitors cannot replicate, and Peterson Institute’s validation of the broader cohort’s claims (~$2.5K real savings vs. $10K claimed) advantages the operator that partners with, rather than disintermediates, existing practices.
Enterprise contracts progressing in parallel: Exact Sciences pilot finalized May 2026 ($250–$330K near-term, up to $15M expansion); Gastro Health two-pilot deployment kicked off in Washington state; second GI Alliance site went live in Mississippi; 80+ care navigators trained on Idaho GI OnDemand with volume up 150% in the first week. Washington Gastroenterology publicly reported a 72% reduction in time-to-procedure and $5.4M in new revenue attributable to the WovenX partnership Web. In June 2025, CRH Medical (a WELL Health subsidiary) announced a strategic partnership with WovenX to advance GI patient access — the kind of channel that meaningfully accelerates distribution into ASCs Web.
Most probable exit is strategic acquisition by a specialty-care roll-up (GI Alliance / Cardinal Health, US Digestive Health), a diagnostics-plus-services platform (Exact Sciences was flagged as a partner-turned-acquirer path before Abbott announced its ~$21B acquisition of Exact Sciences in Nov 2025 Web), a payer-owned services arm (Optum, Elevance/Carelon), or a large virtual-care platform seeking a GI beachhead (Teladoc, Included Health, WELL Health — the latter already partnered via CRH Medical in June 2025 Web). Digital-health M&A activity re-accelerated meaningfully in 2025 with 277 deals in H1 alone and $10.3B in disclosed value, and PE-backed GI roll-ups continue to consolidate at pace, both of which create multiple credible bidders for a scaled, GI-specialized asset over a 5–7 year horizon Web.